Sisters airs on TLC and the reality series follows the lives of siblings Tammy and Amy Slaton from Kentucky. First airing in ...

He spotted the opportunity to invest in weight-loss drugs in 2023 before they exploded in 2024, and was an early AI mover, which he spied as a game changer in late 2022, early 2023. It's all about ...

The TODAY weatherman and 3rd Hour of TODAY co-host, 70, appears on the cover of People's Spring Health issue this month.

Don’t start this journey just to fit into old jeans, be summertime fine or to impress people who aren’t invested in your healing. Start it because you want to live—fully and freely. Your “why” has to ...

Drugmakers are introducing discounts and lower-cost options for consumers who have to pay for GLP-1 drugs out of pocket. News outlets look at the trend in pricing for drugs like Wegovy and Zepbound.

The supply of GLP-1 drugs has been increasing, but they’re still expensive for most patients. Here are answers to some ...

Drugmakers are offering the blockbuster medications at steep discounts to people willing to pay out of pocket.

Jim Gaffigan opens up about his 50lb weight loss using Mounjaro, sharing insights on feeling better, health benefits and ...

Norway's parliament on Wednesday rejected a proposal to have the country's $1.9 trillion sovereign wealth fund, the world's ...

Deciding which jab to nab? When it comes to shedding pounds and cinching inches, a new study puts one weight loss drug ahead of another. Published in the New England Journal of Medicine ...

The Trump administration on Monday singled out powerful new weight-loss drugs including Wegovy and Zepbound as targets in its ...

Another win for the jab. GLP-1 drugs like Ozempic and Wegovy have been linked to a host of benefits beyond diabetes management and weight loss, from reduced dementia risk to addiction treatment.